| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
56,542 |
50,901 |
$2.04M |
| 0450 |
Emergency room services |
9,267 |
8,479 |
$1.31M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,538 |
10,718 |
$1.14M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,169 |
2,114 |
$775K |
| 80053 |
Comprehensive metabolic panel |
30,608 |
27,825 |
$613K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,828 |
18,299 |
$610K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,399 |
3,316 |
$561K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,560 |
6,409 |
$555K |
| 99070 |
|
29,273 |
13,874 |
$489K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,964 |
6,424 |
$460K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
36,570 |
33,062 |
$391K |
| 99199 |
Unlisted special service, procedure or report |
6,176 |
5,475 |
$384K |
| Z7502 |
|
9,521 |
9,359 |
$355K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,618 |
6,261 |
$300K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,339 |
1,313 |
$281K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,535 |
3,445 |
$240K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,643 |
1,542 |
$208K |
| 71045 |
Radiologic examination, chest; single view |
10,090 |
9,575 |
$199K |
| 59050 |
|
1,381 |
875 |
$177K |
| 83880 |
|
4,168 |
3,952 |
$174K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,546 |
1,485 |
$167K |
| J3490 |
Unclassified drugs |
23,117 |
14,349 |
$158K |
| 84484 |
|
10,863 |
9,563 |
$156K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,520 |
3,320 |
$152K |
| 71046 |
Radiologic examination, chest; 2 views |
4,091 |
3,987 |
$142K |
| 80306 |
|
4,249 |
4,050 |
$120K |
| 99221 |
|
389 |
210 |
$110K |
| 81001 |
|
19,024 |
17,872 |
$105K |
| 83690 |
|
9,379 |
8,793 |
$104K |
| 87275 |
|
8,239 |
7,997 |
$102K |
| 87276 |
|
8,239 |
7,996 |
$95K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,084 |
1,060 |
$93K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,409 |
4,195 |
$72K |
| 80299 |
|
3,046 |
1,636 |
$65K |
| 87280 |
|
3,740 |
3,625 |
$63K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,451 |
7,807 |
$62K |
| 99218 |
|
369 |
303 |
$62K |
| 76801 |
|
637 |
572 |
$60K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,019 |
991 |
$59K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
149 |
148 |
$58K |
| 81025 |
|
9,699 |
9,217 |
$55K |
| 87430 |
|
3,331 |
3,256 |
$53K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
3,255 |
2,032 |
$51K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
918 |
897 |
$51K |
| 87088 |
|
4,807 |
4,658 |
$51K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
195 |
192 |
$50K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
854 |
813 |
$49K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,800 |
1,566 |
$49K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
519 |
509 |
$48K |
| 87070 |
|
3,214 |
3,128 |
$46K |
| Z7610 |
|
5,221 |
3,009 |
$44K |
| 83605 |
|
2,667 |
2,418 |
$43K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
344 |
339 |
$42K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,574 |
1,539 |
$39K |
| 71250 |
|
221 |
220 |
$37K |
| 59025 |
Fetal non-stress test |
1,291 |
786 |
$37K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,202 |
5,879 |
$37K |
| 83735 |
|
3,909 |
3,327 |
$37K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,400 |
3,319 |
$36K |
| 87040 |
|
1,800 |
1,264 |
$35K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,379 |
4,838 |
$34K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
1,285 |
902 |
$34K |
| 76830 |
Ultrasound, transvaginal |
387 |
379 |
$32K |
| 73560 |
|
1,238 |
883 |
$32K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,021 |
3,249 |
$31K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
406 |
398 |
$31K |
| 84702 |
|
1,323 |
1,184 |
$29K |
| 73610 |
|
722 |
695 |
$25K |
| 73630 |
|
765 |
738 |
$25K |
| 81003 |
|
4,599 |
4,470 |
$24K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
99 |
95 |
$24K |
| Z9725 |
|
519 |
519 |
$22K |
| 36415 |
Collection of venous blood by venipuncture |
3,083 |
2,922 |
$22K |
| 87186 |
|
1,827 |
1,762 |
$22K |
| 85379 |
|
1,380 |
1,351 |
$21K |
| 0250 |
|
6,208 |
3,200 |
$21K |
| 94060 |
|
309 |
309 |
$20K |
| 73564 |
|
431 |
424 |
$20K |
| 87797 |
|
695 |
666 |
$20K |
| 85610 |
|
3,452 |
3,058 |
$19K |
| 94644 |
|
598 |
550 |
$19K |
| 88342 |
|
176 |
175 |
$19K |
| 86141 |
|
1,019 |
1,001 |
$18K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
332 |
301 |
$18K |
| 73030 |
|
440 |
426 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
935 |
850 |
$14K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,823 |
1,763 |
$14K |
| 87081 |
|
1,223 |
1,173 |
$13K |
| 94726 |
|
279 |
279 |
$13K |
| 90715 |
|
241 |
241 |
$13K |
| 94729 |
|
283 |
283 |
$13K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
278 |
254 |
$13K |
| 73562 |
|
398 |
365 |
$12K |
| 85730 |
|
1,226 |
1,180 |
$11K |
| 86900 |
|
1,193 |
1,154 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,841 |
1,673 |
$10K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
101 |
68 |
$10K |
| 82962 |
|
1,976 |
1,896 |
$9K |
| 86901 |
|
1,608 |
1,539 |
$9K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
97 |
87 |
$9K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,747 |
1,610 |
$9K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
59 |
59 |
$9K |
| 93971 |
|
58 |
56 |
$7K |
| 73565 |
|
338 |
333 |
$7K |
| 82010 |
|
596 |
577 |
$7K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
145 |
144 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,206 |
1,122 |
$6K |
| 87807 |
|
376 |
342 |
$6K |
| 87806 |
|
104 |
102 |
$6K |
| 73130 |
|
154 |
151 |
$6K |
| 96367 |
|
80 |
71 |
$6K |
| J2060 |
Injection, lorazepam, 2 mg |
1,021 |
897 |
$5K |
| 72100 |
|
145 |
144 |
$5K |
| 84439 |
|
371 |
367 |
$5K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
55 |
55 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
734 |
549 |
$5K |
| 87210 |
|
675 |
651 |
$5K |
| 86850 |
|
626 |
608 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
499 |
477 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
522 |
482 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
235 |
233 |
$4K |
| 73502 |
|
73 |
68 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
17 |
17 |
$4K |
| 82803 |
|
127 |
95 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
220 |
201 |
$3K |
| 85651 |
|
677 |
661 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
446 |
300 |
$3K |
| 84703 |
|
252 |
249 |
$3K |
| 86480 |
|
58 |
58 |
$3K |
| 74018 |
|
86 |
80 |
$3K |
| 87449 |
|
226 |
222 |
$3K |
| 95816 |
|
40 |
40 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$2K |
| 82550 |
|
269 |
254 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
413 |
395 |
$2K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
770 |
729 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
404 |
288 |
$2K |
| 73020 |
|
84 |
80 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
311 |
304 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
237 |
185 |
$2K |
| 45384 |
|
47 |
47 |
$2K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
12 |
12 |
$2K |
| 95819 |
|
29 |
29 |
$2K |
| 84145 |
|
59 |
59 |
$2K |
| 86592 |
|
173 |
170 |
$2K |
| 73110 |
|
40 |
40 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
189 |
187 |
$2K |
| 0270 |
|
182 |
95 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
397 |
388 |
$1K |
| 86762 |
|
44 |
44 |
$1K |
| 94617 |
|
14 |
14 |
$1K |
| 73120 |
|
42 |
39 |
$1K |
| 74740 |
|
12 |
12 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
180 |
177 |
$978.55 |
| J1630 |
Injection, haloperidol, up to 5 mg |
212 |
183 |
$914.55 |
| 80320 |
|
455 |
431 |
$845.99 |
| 88304 |
|
13 |
13 |
$838.20 |
| 87147 |
|
82 |
79 |
$617.63 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
161 |
159 |
$593.33 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
15 |
12 |
$589.54 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
96 |
89 |
$522.39 |
| 80061 |
Lipid panel |
25 |
25 |
$485.17 |
| J1940 |
Injection, furosemide, up to 20 mg |
136 |
93 |
$460.48 |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
15 |
13 |
$424.89 |
| 86308 |
|
52 |
52 |
$406.24 |
| 87205 |
|
56 |
54 |
$315.77 |
| A9270 |
Non-covered item or service |
1,576 |
721 |
$313.25 |
| 72170 |
|
14 |
14 |
$285.42 |
| 84550 |
|
26 |
25 |
$195.55 |
| 82950 |
|
18 |
18 |
$178.16 |
| 0637 |
|
1,064 |
676 |
$151.24 |
| J2704 |
Injection, propofol, 10 mg |
46 |
41 |
$134.91 |
| 85008 |
|
104 |
100 |
$109.77 |
| J1644 |
Injection, heparin sodium, per 1000 units |
26 |
14 |
$109.55 |
| A4554 |
Disposable underpads, all sizes |
16 |
13 |
$59.04 |
| 0271 |
|
16 |
12 |
$17.96 |